Literature DB >> 3989872

Mitochondrial respiration following acute hypoxia in the perfused rat heart.

E O Fuller, D I Goldberg, J W Starnes, L M Sacks, M Delivoria-Papadopoulos.   

Abstract

Mitochondria isolated from tissues of hypoxic animals have increased respiratory capacity (State 3 respiration) when assayed in vitro at ambient oxygen tensions. The present study utilized the isolated perfused rat heart to determine whether or not this change could be produced in the absence of the neural and hormonal changes that accompany hypoxia in vivo. Following 10-min single pass retrograde perfusion with normoxic Krebs-Henseleit buffer (PO2 greater than or equal to 600 mmHg), perfusion was continued for up to 15 min with either normoxic or hypoxic buffer (PO2 less than or equal to 150 mmHg). After 10 min of hypoxic perfusion State 3 respiration of the mitochondria from the hypoxic hearts was 13 to 15% higher (P less than or equal to 0.05) than that of normoxic hearts when assayed with either glutamate/malate or succinate as substrate but was unchanged when TMPD and ascorbate was the substrate. Succinate-supported State 4 respiration of the hypoxic mitochondria also showed a small (10%) but significant (P less than or equal to 0.05) increase. These changes were not abolished by preperfusing the heart with propranolol (10(-7), 10(-6), or 10(-5) M) indicating that the response was not attributable to release of local stores of catecholamines. Respiratory control and ADP/O ratios as well as contents of cytochrome c and aa3 of the mitochondria from the hypoxic hearts were similar to those of normoxic hearts indicating that the mitochondria remained intact and tightly coupled. We concluded that the hypoxia-induced increase in mitochondrial State 3 respiration, while independent of neural and hormonal influences from the body requires an intracellular event, since they cannot be reproduced by subjecting isolated mitochondria to hypoxia in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989872     DOI: 10.1016/s0022-2828(85)80093-6

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Impaired oxidative phosphorylation in overtrained rat myocardium.

Authors:  Lumme Kadaja; Margus Eimre; Kalju Paju; Mart Roosimaa; Taavi Põdramägi; Priit Kaasik; Ando Pehme; Ehte Orlova; Margareeta Mudist; Nadezhda Peet; Andres Piirsoo; Teet Seene; Frank N Gellerich; Enn K Seppet
Journal:  Exp Clin Cardiol       Date:  2010

2.  Acute effects of hypoxia and phosphate on two populations of heart mitochondria.

Authors:  J M Duan; M Karmazyn
Journal:  Mol Cell Biochem       Date:  1989-10-05       Impact factor: 3.396

3.  Direct measurement of energy fluxes from mitochondria into cytoplasm in permeabilized cardiac cells in situ: some evidence for Mitochondrial Interactosome.

Authors:  Natalia Timohhina; Rita Guzun; Kersti Tepp; Claire Monge; Minna Varikmaa; Heiki Vija; Peeter Sikk; Tuuli Kaambre; Dan Sackett; Valdur Saks
Journal:  J Bioenerg Biomembr       Date:  2009-07-14       Impact factor: 2.945

4.  Glutamine catabolism by heart muscle. Properties of phosphate-activated glutaminase.

Authors:  D Nelson; W L Rumsey; M Erecińska
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

5.  Intracellular pH in sheep Purkinje fibres and ferret papillary muscles during hypoxia and recovery.

Authors:  D Ellis; J Noireaud
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

6.  Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage.

Authors:  K Veitch; A Hombroeckx; D Caucheteux; H Pouleur; L Hue
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

7.  The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations.

Authors:  Thor Allan Stenberg; Anders Benjamin Kildal; Espen Sanden; Ole-Jakob How; Martin Hagve; Kirsti Ytrehus; Terje S Larsen; Truls Myrmel
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.